Stockreport

IceCure Reports 2025 Full Year Financial & Operational Results

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF Record 4th quarter and full year sales of $1.3 million and $3.4 million, respectivelyStrong commercial momentum for ProSense® in the U.S. and globally following FDA clea [Read more]